AOD9604, an orally active peptide for the treatment of obesity: Results of a phase 2b study

Wittert, G, Caterson, I, Proietto, J, Strauss, B, Prins, J, Stocks, A, Vos, E, Belyea, C and Herd, C (2005). AOD9604, an orally active peptide for the treatment of obesity: Results of a phase 2b study. In: Diabetes. 65th Annual Meeting of the American-Diabetes-Association, San Diego Ca, (A440-A441). Jun 10-14, 2005.

Author Wittert, G
Caterson, I
Proietto, J
Strauss, B
Prins, J
Stocks, A
Vos, E
Belyea, C
Herd, C
Title of paper AOD9604, an orally active peptide for the treatment of obesity: Results of a phase 2b study
Conference name 65th Annual Meeting of the American-Diabetes-Association
Conference location San Diego Ca
Conference dates Jun 10-14, 2005
Proceedings title Diabetes   Check publisher's open access policy
Journal name Diabetes   Check publisher's open access policy
Publication Year 2005
Sub-type Published abstract
ISSN 0012-1797
Volume 54
Start page A440
End page A441
Total pages 2
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Fri, 22 Nov 2013, 18:16:04 EST by System User